Amicogen is going through a period of significant business change.
First, for the enzyme/biopharmaceutical business, which has been Amicogen’s cash cow, we have been making a lot of preparations to break out of the regional limitations of China and limitations of the business area that has been centered on antibiotics. We are expanding our enzyme business to food, bioprocess, and therapeutic enzymes centered on antibiotic enzymes, and we are expanding the business centered on China to global businesses such as third countries. The DX business has also overcome many difficulties and succeeded in the 7-ADCA business, and the 7-ACA business has been delayed, but we are continuing to develop it. Accordingly, we expect good results shortly. Following the existing enzyme business, we are expanding into the enzyme therapeutics business, including the next-generation antibiotic business, by entering the endolysin business, which is an enzyme substance, and we will grow it into a new growth engine business by accumulating experience and internal capabilities through interchanges with global leading companies in this field.
Next, for the healthcare business, which has been driving Amicogen’s growth, we have the world’s best technology and products as eco-friendly functional biomaterials using enzymes and fermentation technology. Collagen tripeptide, NAG, DCI, grain fermentase, hangover relieving enzyme, and Bifidobacterium of Amicogen’s subsidiary Bifido are the world’s best functional dry materials for healthcare. We have been continuously growing the Amicogen and Knutra brands in the global healthcare market, focusing on the B2B business of functional materials under the brand Amicogen for a long time and selling our functional products under the brand Knutra. Recently, our raw material of collagen was recognized as a functional individual type by the KFDA, and we plan to strategically expand our healthcare business by using the newly expanded factory for producing dry finished products. We are continuously developing technology for new functional individual types and plan to continue to introduce new functional materials to the market.